Enanta Pharmaceuticals, Inc. (ENTA)
10.71
-0.44
(-3.95%)
USD |
NASDAQ |
Oct 30, 16:00
10.76
+0.06
(+0.51%)
After-Hours: 20:00
Enanta Pharmaceuticals Price to Book Value : 3.086 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 3.086 |
| October 29, 2026 | 3.213 |
| October 28, 2026 | 3.328 |
| October 27, 2026 | 3.509 |
| October 26, 2026 | 3.458 |
| October 23, 2026 | 3.354 |
| October 22, 2026 | 3.348 |
| October 21, 2026 | 3.259 |
| October 20, 2026 | 3.362 |
| October 19, 2026 | 3.288 |
| October 16, 2026 | 3.198 |
| October 15, 2026 | 3.305 |
| October 14, 2026 | 3.221 |
| October 13, 2026 | 3.319 |
| October 12, 2026 | 3.544 |
| October 09, 2026 | 3.602 |
| October 08, 2026 | 3.486 |
| October 07, 2026 | 3.564 |
| October 06, 2026 | 3.506 |
| October 05, 2026 | 3.630 |
| October 02, 2026 | 3.734 |
| October 01, 2026 | 3.700 |
| September 30, 2026 | 3.798 |
| September 29, 2026 | 3.642 |
| September 28, 2026 | 3.635 |
| Date | Value |
|---|---|
| September 25, 2026 | 3.423 |
| September 24, 2026 | 3.458 |
| September 23, 2026 | 3.443 |
| September 22, 2026 | 3.578 |
| September 21, 2026 | 3.489 |
| September 18, 2026 | 3.515 |
| September 17, 2026 | 3.607 |
| September 16, 2026 | 3.659 |
| September 15, 2026 | 3.541 |
| September 14, 2026 | 3.780 |
| September 11, 2026 | 3.734 |
| September 10, 2026 | 3.659 |
| September 09, 2026 | 3.815 |
| September 08, 2026 | 3.890 |
| September 04, 2026 | 4.057 |
| September 03, 2026 | 4.040 |
| September 02, 2026 | 4.060 |
| September 01, 2026 | 3.892 |
| August 31, 2026 | 3.841 |
| August 28, 2026 | 3.918 |
| August 27, 2026 | 3.976 |
| August 26, 2026 | 4.077 |
| August 25, 2026 | 4.057 |
| August 24, 2026 | 4.062 |
| August 21, 2026 | 3.881 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Perspective Therapeutics, Inc. | 0.4051 |
| Vertex Pharmaceuticals, Inc. | 6.993 |
| Coherus Oncology, Inc. | 2.108 |
| BridgeBio Pharma, Inc. | -- |
| RenovoRx, Inc. | 6.684 |
Price to Book Value Related Metrics
| PS Ratio | 4.442 |
| Price | 10.71 |
| Earnings Yield | -22.51% |
| Market Cap | 311.88M |